Diarylpyrimidine-evolved HIV-1 non-nucleoside reverse transcriptase inhibitors show improved resistance and pharmacokinetic profiles against highly drug-resistant strains
Wang, Z., Rumrill, S.R., Kang, D., Desta, S., Feng, D., De Clercq, E., Pannecouque, C., Chen, C.H., Arnold, E., Ruiz, F.X., Liu, X., Zhan, P.To be published.